AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION: Form 990, tax year 2022
View the entire original 990 at ProPublica ↗
- Organization
- AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION (EIN 23-7033369)
- Tax period
- 2022-06-01 to 2023-05-31
- Filed
- 2024-04-01
- IRS object ID
- 202420929349300762
- Schema version
- 2022v5.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2024-04-01T14:52:33-05:00 | ReturnTs |
| Tax Period End | 2023-05-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 571157523 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | APRIO LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 111 ROCKVILLE PIKE SUITE 600 | AddressLine1Txt |
| City | ROCKVILLE | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20850 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2022-06-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 237033369 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | AMERICAN SOCIETY OF HEALTH-SYSTEM | BusinessNameLine1Txt |
| Business Name Line2 | PHARMACISTS RESEARCH AND EDUCATION FDTN | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | AMER | BusinessNameControlTxt |
| Phone | 3016648612 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 4500 EAST-WEST HIGHWAY 900 | AddressLine1Txt |
| City | BETHESDA | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | STEVEN RUBLOFF | PersonNm |
| Person Title | CHIEF EXECUTIVE OFFICER | PersonTitleTxt |
| Phone | 3016648612 | PhoneNum |
| Signature | 2024-03-25 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Signing Officer SigningOfficerGrp
Person Full Name PersonFullName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person First | STEVEN | PersonFirstNm |
| Person Last | RUBLOFF | PersonLastNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| SSN | 999009999 | SSN |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IRS Responsible Prty Info Curr | 0 | IRSResponsiblePrtyInfoCurrInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | STACY CULLEN | PreparerPersonNm |
| PTIN | P00974308 | PTIN |
| Phone | 3012316200 | PhoneNum |
| Preparation | 2024-03-25 | PreparationDt |
Additional Filer Information AdditionalFilerInformation
Trusted Customer TrustedCustomerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Trusted Customer | 0 | TrustedCustomerCd |
| Authentication Assurance Level | AAL1 | AuthenticationAssuranceLevelCd |
| Identity Assurance Level | IAL1 | IdentityAssuranceLevelCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2022 | TaxYr |
| Build TS | 2023-04-26 12:10:37Z | BuildTS |
Form 990 IRS990
Doing Business As Name DoingBusinessAsName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ASHP FOUNDATION | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | STEVEN RUBLOFF | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 4500 EAST-WEST HIGHWAY 900 | AddressLine1Txt |
| City | BETHESDA | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $14,409,655 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.ASHPFOUNDATION.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1968 | FormationYr |
| Legal Domicile State | MD | LegalDomicileStateCd |
| Activity Or Mission | THE MISSION OF THE ASHP FOUNDATION IS TO SUPPORT ASHP BY ADVANCING (CONTINUED ON SCHEDULE O)THE PROFESSIONAL PRACTICE OF PHARMACISTS AND THE PHARMACY WORKFORCE BY FUNDING RESEARCH AND EDUCATION THAT IMPROVES HEALTH OUTCOMES THROUGH OPTIMAL, SAFE AND EFFECTIVE MEDICATION USE. | ActivityOrMissionDesc |
| Voting Members Governing Body | 14 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 10 | VotingMembersIndependentCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Total Volunteers | 100 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $1,421,259 | PYContributionsGrantsAmt |
| CY Contributions Grants | $1,414,901 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $1,380,758 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $1,439,967 | CYProgramServiceRevenueAmt |
| PY Investment Income | $451,714 | PYInvestmentIncomeAmt |
| CY Investment Income | $423,877 | CYInvestmentIncomeAmt |
| PY Other Revenue | $0 | PYOtherRevenueAmt |
| CY Other Revenue | $0 | CYOtherRevenueAmt |
| PY Total Revenue | $3,253,731 | PYTotalRevenueAmt |
| CY Total Revenue | $3,278,745 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $384,147 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $526,582 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $1,650,828 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $1,717,851 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $753,099 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $712,310 | PYOtherExpensesAmt |
| CY Other Expenses | $749,234 | CYOtherExpensesAmt |
| PY Total Expenses | $2,747,285 | PYTotalExpensesAmt |
| CY Total Expenses | $2,993,667 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $506,446 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $285,078 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $13,385,213 | TotalAssetsBOYAmt |
| Total Assets EOY | $12,995,656 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $941,454 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $811,149 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $12,443,759 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $12,184,507 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | OUR MISSION: SUPPORT ASHP BY ADVANCING THE PROFESSIONAL PRACTICE OF PHARMACISTS AND THE PHARMACY WORKFORCE BY FUNDING RESEARCH AND EDUCATION THAT IMPROVES HEALTH OUTCOMES THROUGH OPTIMAL, SAFE AND EFFECTIVE MEDICATION USE. OUR VISION: AS THE PHILANTHROPIC ARM OF ASHP, THE FOUNDATION SHARES ASHP'S VISION THAT MEDICATION USE WILL BE OPTIMAL, SAFE, AND EFFECTIVE FOR ALL PEOPLE ALL OF THE TIME. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $987,225 | ExpenseAmt |
| Grant | $194,227 | GrantAmt |
| Revenue | $741,425 | RevenueAmt |
| Desc | EXCELLENCE IN PHARMACY PRACTICE & LEADERSHIP DEVELOPMENT: RECOGNIZE AND PROMOTE EFFORTS THAT FOSTER EXCELLENCE AND GROWTH OF HEALTH-SYSTEM PHARMACY.ASHP STUDENT LEADERSHIP AWARD: THIS PROGRAM, FUNDED THROUGH THE DAVID A. ZILZ FUND, IS ADMINISTERED BY THE ASHP PHARMACY STUDENT FORUM IN COLLABORATION WITH THE ASHP FOUNDATION. TWELVE STUDENTS WHO DEMONSTRATE HIGH ACADEMIC ACHIEVEMENT, EXCEPTIONAL INTEREST IN HEALTH-SYSTEM PHARMACY PRACTICE, AND OUTSTANDING LEADERSHIP SKILLS WERE RECOGNIZED. THE AWARDEES RECEIVED A PLAQUE, A $2,000 AWARD AND AN ASHP DRUG INFORMATION LIBRARY. EACH AWARDEE SUBMITTED A PLAN TO RAISE STUDENT AWARENESS OF THE ASHP PRACTICE ADVANCEMENT INITIATIVE. AWARDEES WILL BE SURVEYED TO COLLECT INFORMATION ON IMPLEMENTATION AND OUTCOMES OF THEIR PLAN.PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM: THE 2022 PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM WAS SUPPORTED BY SAMSON MEDICAL TECHNOLOGIES AND MEDI-DOSE. THIS UNIQUE AWARD RECOGNIZES EXCELLENCE AND LEADERSHIP IN THE TRAINING AND MENTORING OF PHARMACY RESIDENTS. THE PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM RECOGNIZES A PRECEPTOR, NEW PRECEPTOR AND PROGRAM. THE OBJECTIVES OF THIS PROGRAM ARE TO: 1) RECOGNIZE THE ACHIEVEMENTS OF RESIDENCY PROGRAMS AND PHARMACISTS WHO HAVE DEMONSTRATED EXCELLENCE AND LEADERSHIP IN THE TRAINING OF PHARMACY RESIDENTS AND 2) WIDELY DISSEMINATE THE RESULTS OF THESE ACCOMPLISHMENTS TO FOSTER INNOVATIONS IN PHARMACY RESIDENT TRAINING. EACH AWARDEE WILL ALSO PRESENT AN EDUCATIONAL WEBINAR ON A RESIDENT PROFESSIONAL DEVELOPMENT TOPICS. THE WEBINARS ARE RECORDED AND MADE AVAILABLE FOR ON-DEMAND ACCESS. LITERATURE AWARDS PROGRAM: THE ASHP FOUNDATION LITERATURE AWARDS PROGRAM RECOGNIZES IMPORTANT CONTRIBUTIONS TO THE BIOMEDICAL LITERATURE BY PHARMACISTS. THIS PROGRAM, ADMINISTERED BY THE ASHP FOUNDATION SINCE 1971, RECOGNIZES TO STIMULATE INNOVATION AND FOSTERS IMPROVEMENT IN THE QUALITY OF THE EVIDENCE. AWARDEES ARE RECOGNIZED THROUGH VARIOUS ELECTRONIC PLATFORMS AND AT THE ASHP MIDYEAR CLINICAL MEETING. ASHP FOUNDATION PHARMACY STUDENT SCHOLARSHIP: IN FY23, THE ASHP FOUNDATION LAUNCHED A PHARMACY STUDENT SCHOLARSHIP. THE INAUGURAL PROGRAM, PART OF ASHP'S COMMITMENT TO INCREASING DIVERSITY, EQUITY, AND INCLUSION IN THE PHARMACY WORKFORCE, WAS SUPPORTED BY APEXUS. THE PROGRAM AWARDED A TOTAL OF $25,000 IN SCHOLARSHIPS TO P3 AND P4 PHARMACY STUDENTS ENROLLED AT US-ACCREDITED HISTORICALLY BLACK COLLEGES AND UNIVERSITIES (HBCUS) FOR THE 2023-2024 ACADEMIC YEAR. THE ASHP FOUNDATION PARTNERED WITH FIVE ACCREDITED HBCU SCHOOLS OF PHARMACY AND PROVIDED EACH WITH $5,000 IN FUNDING FOR DISBURSEMENT TO RECIPIENTS. EACH HBCU SCHOOLS OF PHARMACY WILL SELECT ONE RECIPIENT TO RECEIVE $5,000 OR TWO RECIPIENTS TO RECEIVE $2,500 EACH. THE RECIPIENTS WILL BE SELECTED BY THEIR RESPECTIVE SCHOOLS IN FALL 2023 AND WILL HAVE THE OPPORTUNITY TO PARTICIPATE IN ADDITIONAL ENGAGEMENT ACTIVITIES WITH ASHP IN FY24. PHARMACIST NUTRITION SUPPORT PATIENT-CARE IMPACT PROGRAM: SUPPORTED BY AN EDUCATIONAL GRANT FROM BAXTER AND OFFERED IN COLLABORATION WITH ASHP'S SECTION ON CLINICAL SPECIALISTS AND SCIENTISTS, THE PHARMACIST NUTRITION SUPPORT PATIENT-CARE IMPACT PROGRAM DISTANCE PROGRAM IS DESIGNED TO DEVELOP LEADERS WITH KNOWLEDGE AND SKILLS TO OPTIMIZE SAFE AND EFFECTIVE NUTRITIONAL SUPPORT NEEDS OF PATIENTS. THE PROGRAM SUPPORTS COHORTS OF UP TO TEN PHARMACY RESIDENTS IN PGY2 PROGRAMS. THE PROGRAM AND APPLICATION LAUNCHED IN FY23, WITH THE COHORT SELECTED IN FY24. MEDICATION SAFETY SCHOLARS: ASHP FOUNDATION IN PARTNERSHIP WITH EMILY JERRY FOUNDATION AND THE ASHP STUDENT FORUM SELECTED PARTICIPANTS FOR THE MEDICATION SAFETY SCHOLARS PROGRAM. THE PROGRAM IS A DISTANCE IMPACT PROGRAM STRUCTURED TO SUPPORT FIVE P2 AND P3 DOCTOR OF PHARMACY STUDENTS, PAIRED WITH ONE GROUP COACH, TO ENHANCE THEIR KNOWLEDGE AND SKILLS IN MEDICATION SAFETY. PROGRAM PARTICIPANTS MET IN JUNE 2022 AT THE ASHP SUMMER MEETINGS IN PHOENIX, ARIZONA TO SUPPORT A LIVE SESSION AT THE MEETING AND HAVE A NETWORKING DINNER TO CONCLUDE THE PROGRAM AND MEET WITH THE FACULTY IN PERSON. PHARMACY STUDENT CLINICAL SKILLS COMPETITION: ELLA DOMINGO & MARY ROTHENBERGER, PURDUE UNIVERSITY COLLEGE OF PHARMACY COMPETED FOR THE 2022 ASHP NATIONAL CLINICAL SKILLS COMPETITIONS AND WERE AWARDED IN DECEMBER 2022, DURING THE ASHP MIDYEAR CLINICAL MEETING IN LAS VEGAS, NV. THE FOUNDATION HAS SPONSORED THE PHARMACY STUDENT CLINICAL SKILLS COMPETITION (CSC) AT THE ASHP MIDYEAR CLINICAL MEETING 17 YEARS. TEAMS WHO WON PRELIMINARY COMPETITIONS AT THEIR LOCAL PHARMACY SCHOOL PARTICIPATED IN THE COMPETITION. DURING THE CSC, STUDENTS DEMONSTRATE THEIR SKILLS BY ASSESSING PATIENT INFORMATION AND CURRENT THERAPY, IDENTIFYING AND PRIORITIZING DRUG THERAPY PROBLEMS, IDENTIFYING TREATMENT GOALS, AND RECOMMENDING A PHARMACIST CARE PLAN. VISITING LEADERS PROGRAM (VLP): THE VISITING LEADERS PROGRAM, WITH SUPPORT FROM THE DAVID A. ZILZ LEADERS FOR THE FUTURE FUND, HAD ANOTHER SUCCESSFUL YEAR. TEN LEADERS WERE INVOLVED IN 19 RESIDENCY VISITS, REACHING RESIDENTS, IN FY23. THERE WERE TWENTY VISITS SCHEDULED, BUT ONE WAS CANCELLED DUE TO LAST MINUTE CONFLICTS WITH LEADERS' SCHEDULES. OF THE TOTAL VISITS MAJORITY WERE CONDUCTED IN-PERSON.PHARMACY LEADERSHIP ACADEMY (PLA): THE PLA, SUPPORTED IN PART BY A GRANT FROM APEXUS, IS AN ONLINE EDUCATION PROGRAM DESIGNED TO PROVIDE COMPREHENSIVE LEADERSHIP EDUCATION TO PHARMACISTS AND PHARMACY TECHNICIANS. THE PLA CLASS IN FY23 CONSISTED OF 117 PARTICIPANTS, WHO ALSO REMITTED TUITION AND WERE ENROLLED IN THE PROGRAM FROM JULY 2022 JUNE 2023. THE NUMBER OF GRADUATES FROM THIS CLASS BRINGS THE TOTAL NUMBER OF PLA GRADUATES TO 1,178 PHARMACISTS.WILLIAM A. ZELLMER LEADERSHIP LECTURE: WHERE PRACTICE MEETS POLICY: THIS ANNUAL LUNCHEON-LECTURE EVENT, HOSTED BY ASHP IN PARTNERSHIP WITH THE ASHP FOUNDATION, IS DESIGNED TO HONOR THE DISTINGUISHED 40-YEAR ASHP CAREER OF WILLIAM A. ZELLMER AND IS SUPPORTED BY DONORS TO THE ASHP FOUNDATION'S WILLIAM ZELLMER FUND. REAR ADMIRAL KRISTA M. PEDLEY, PHARMD, MS, DIRECTOR OF THE HEALTH RESOURCES AND SERVICES ADMINISTRATION (HRSA) OFFICE OF SPECIAL HEALTH INITIATIVES, AND THE LECTURE CEREMONY OCCURRED ON SEPTEMBER 13, 2022 DURING ASHP'S ANNUAL POLICY WEEK ACTIVITIES. NO EXPENSES WERE INCURRED BY THE ASHP FOUNDATION FOR THIS PROGRAM IN FY23. JOSEPH A. ODDIS ETHICS COLLOQUIUM: THE JOSEPH A. ODDIS ETHICS COLLOQUIUM FOCUSED ON THE TOPIC: ETHICS OF BIG DATA-I POLICY VALUES FOR IMPLEMENTING TODAY'S DATA TECHNOLOGY IN HEALTHCARE SYSTEMS. THE SESSION WAS PLANNED AND LED BY THE PROGRAM CHAIR IN JUNE DURING THE 2022 ASHP SUMMER MEETINGS & EXHIBITION IN PHOENIX, AZ. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $826,512 | ExpenseAmt |
| Grant | $332,355 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc |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| Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $0 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Revenue | $678,542 | RevenueAmt |
| Desc | THE ASHP FOUNDATION CORPORATE PARTNERS PROGRAM IS A STRATEGIC PARTNERSHIP BETWEEN THE ASHP FOUNDATION, ASHP, AND CORPORATIONS WHICH PROMOTES MEDICATION SAFETY AND IMPROVEMENTS IN PATIENT CARE. THE PROGRAM OFFERS A ROBUST MENU OF SPONSORSHIP LEVELS AND BENEFITS FOR COMPANIES, FOCUSED ON COLLABORATION, RECOGNITION, AND INFORMATIONAL OPPORTUNITIES. THERE ARE FOUR SPONSORSHIP LEVELS AND A-LA-CARTE OPPORTUNITIES TO BETTER MEET BUSINESS OBJECTIVES. CORPORATE PARTNERS PROGRAM SPONSORSHIP IS ON AN ANNUAL BASIS. WITH THE GENEROUS SUPPORT OF CORPORATE PARTNERS, THE ASHP FOUNDATION INVESTS IN RESEARCH, AWARDS, EDUCATION, AND LEADERSHIP DEVELOPMENT THAT ADVANCES THE PHARMACY PROFESSION AND ENSURES THE SAFE, EFFECTIVE, AND OPTIMAL USE OF MEDICATIONS. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $1,813,737 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | 0 | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | Yes (1) | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | 0 | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | 0 | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (1) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (1) | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | 0 | ForeignActivitiesInd |
| More Than5000 K To Org | 0 | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | Yes (1) | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | 0 | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | Yes (1) | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | Yes (1) | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 85 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 0 | EmployeeCnt |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | 0 | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 14 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 10 | IndependentVotingMemberCnt |
| Family Or Business Rln | 0 | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | Yes (1) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | 0 | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | 0 | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | TRACY YAKLYVICH | PersonNm |
| Phone | 3016648696 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 4500 EAST-WEST HIGHWAY 900 | AddressLine1Txt |
| City | BETHESDA | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (17 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | OfficerOfficerInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|
| CHRIS HATWIG | ||||||||
| DIRECTOR AT LARGE | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| CHRISTENE JOLOWSKY | ||||||||
| TREASURER | 1.00 | 4.00 | Yes (X) | $0 | $0 | $0 | Yes (X) | |
| ELLEN WETTERLING | ||||||||
| DIRECTOR AT LARGE | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| KELLY M SMITH | ||||||||
| CHAIR | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | Yes (X) | |
| KEN PEREZ | ||||||||
| VICE CHAIR | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | Yes (X) | |
| LINDA S TYLER | ||||||||
| IMMEDIATE PAST PRESIDENT OF ASHP | 1.00 | 1.00 | Yes (X) | $0 | $10,500 | $0 | ||
| LINDSEY THOMAS | ||||||||
| DIRECTOR AT LARGE | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| PAUL C WALKER | ||||||||
| PRESIDENT OF ASHP | 1.00 | 5.00 | Yes (X) | $0 | $10,000 | $0 | ||
| PAUL W ABRAMOWITZ | ||||||||
| PRESIDENT | 3.00 | 40.00 | Yes (X) | $0 | $1,056,203 | $62,392 | Yes (X) | |
| ROGER ANDERSON | ||||||||
| DIRECTOR AT LARGE | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| SCOTT M SAMSON | ||||||||
| DIRECTOR AT LARGE | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| STEVEN A RUBLOFF | ||||||||
| SECRETARY AND CEO | 40.00 | 0.00 | Yes (X) | $375,648 | $0 | $71,543 | Yes (X) | |
| THOMAS J RICE | ||||||||
| DIRECTOR AT LARGE | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| WENDY HORTON | ||||||||
| DIRECTOR AT LARGE | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| BARBARA NUSSBAUM | ||||||||
| VP, RESEARCH AND EDUCATION | 40.00 | 0.00 | $194,806 | $0 | $62,519 | Yes (X) | ||
| MARTHA CREWS | ||||||||
| VP, DEVELOPMENT | 40.00 | 0.00 | $139,571 | $0 | $48,033 | Yes (X) | ||
| STEPHANIE BROWN | ||||||||
| DIRECTOR, OPERATIONS | 40.00 | 0.00 | $129,291 | $0 | $27,155 | Yes (X) | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $839,316 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $1,076,703 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $271,642 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 4 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
| Cntrct Rcvd Greater Than100 K | 0 | CntrctRcvdGreaterThan100KCnt |
| Related Organizations | $358,050 | RelatedOrganizationsAmt |
| All Other Contributions | $1,056,851 | AllOtherContributionsAmt |
| Total Contributions | $1,414,901 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (3 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt | ExclusionExclusionAmt |
|---|---|---|---|---|
| PHARMACY LEADERSHIP ACADEMY | 611430 | $741,425 | $741,425 | |
| CORPORATE PARTNER PROGRAM | 611430 | $678,542 | $678,542 | |
| SPONSORSHIPS | 900099 | $20,000 | $20,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $1,439,967 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $436,902 | TotalRevenueColumnAmt |
| Exclusion | $436,902 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $11,117,885 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $11,130,910 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | -$13,025 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$13,025 | TotalRevenueColumnAmt |
| Exclusion | -$13,025 | ExclusionAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $3,278,745 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $1,419,967 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $443,877 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part IX | Yes (X) | InfoInScheduleOPartIXInd |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $511,482 | TotalAmt |
| Program Services | $511,482 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $15,100 | TotalAmt |
| Program Services | $15,100 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,048,566 | TotalAmt |
| Program Services | $443,212 | ProgramServicesAmt |
| Management And General | $198,262 | ManagementAndGeneralAmt |
| Fundraising | $407,092 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $546,031 | TotalAmt |
| Program Services | $230,799 | ProgramServicesAmt |
| Management And General | $103,243 | ManagementAndGeneralAmt |
| Fundraising | $211,989 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $10,604 | TotalAmt |
| Program Services | $4,482 | ProgramServicesAmt |
| Management And General | $2,005 | ManagementAndGeneralAmt |
| Fundraising | $4,117 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $29,109 | TotalAmt |
| Program Services | $12,304 | ProgramServicesAmt |
| Management And General | $5,504 | ManagementAndGeneralAmt |
| Fundraising | $11,301 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $83,541 | TotalAmt |
| Program Services | $35,311 | ProgramServicesAmt |
| Management And General | $15,796 | ManagementAndGeneralAmt |
| Fundraising | $32,434 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $10,910 | TotalAmt |
| Management And General | $10,910 | ManagementAndGeneralAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $49,316 | TotalAmt |
| Management And General | $49,316 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $435,044 | TotalAmt |
| Program Services | $422,175 | ProgramServicesAmt |
| Management And General | $364 | ManagementAndGeneralAmt |
| Fundraising | $12,505 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $59,225 | TotalAmt |
| Program Services | $48,848 | ProgramServicesAmt |
| Management And General | $2,923 | ManagementAndGeneralAmt |
| Fundraising | $7,454 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $137,455 | TotalAmt |
| Program Services | $45,818 | ProgramServicesAmt |
| Management And General | $25,430 | ManagementAndGeneralAmt |
| Fundraising | $66,207 | FundraisingAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $42,206 | TotalAmt |
| Program Services | $42,206 | ProgramServicesAmt |
Other Expenses OtherExpensesGrp (2 entries)
| DescDesc | TotalTotalAmt | Management And GeneralManagementAndGeneralAmt | Program ServicesProgramServicesAmt |
|---|---|---|---|
| CREDIT CARD FEES | $13,078 | $13,078 | |
| HONORARIA | $2,000 | $2,000 |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,993,667 | TotalAmt |
| Program Services | $1,813,737 | ProgramServicesAmt |
| Management And General | $426,831 | ManagementAndGeneralAmt |
| Fundraising | $753,099 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $506,045 | BOYAmt |
| EOY | $656,263 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $547,495 | BOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,390,682 | BOYAmt |
| EOY | $958,430 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $74,420 | BOYAmt |
| EOY | $154,944 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $62,661 | BOYAmt |
| EOY | $14,946 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $294,308 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $222,832 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $99,682 | BOYAmt |
| EOY | $71,476 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $10,540,167 | BOYAmt |
| EOY | $10,955,064 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $115,405 | BOYAmt |
| EOY | $78,230 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $48,656 | BOYAmt |
| EOY | $106,303 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $13,385,213 | BOYAmt |
| EOY | $12,995,656 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $177,452 | BOYAmt |
| EOY | $199,420 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $764,002 | BOYAmt |
| EOY | $611,729 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $941,454 | BOYAmt |
| EOY | $811,149 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,083,557 | BOYAmt |
| EOY | $3,157,407 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $9,360,202 | BOYAmt |
| EOY | $9,027,100 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $12,443,759 | BOYAmt |
| EOY | $12,184,507 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $13,385,213 | BOYAmt |
| EOY | $12,995,656 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | $285,078 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$544,330 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Info In Schedule O Part XII | Yes (X) | InfoInScheduleOPartXIIInd |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consol And Sep Basis Fincl Stmt | Yes (X) | ConsolAndSepBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $1,768,602 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $928,082 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $2,768,012 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $1,421,259 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $1,414,901 | CurrentTaxYearAmt |
| Total | $8,300,856 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $1,768,602 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $928,082 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $2,768,012 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $1,421,259 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $1,414,901 | CurrentTaxYearAmt |
| Total | $8,300,856 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $3,398,472 | SubstantialContributorsTotAmt |
| Public Support Total170 | $4,902,384 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $406,338 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $303,024 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $338,642 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $446,440 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $436,902 | CurrentTaxYearAmt |
| Total | $1,931,346 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $10,232,202 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $5,099,974 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.47910 | PublicSupportCY170Pct |
| Public Support PY170 | 0.42600 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $7,284,777 | BeginningYearBalanceAmt |
| Contributions | $5,804 | ContributionsAmt |
| Investment Earnings Or Losses | -$59,928 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $140,955 | OtherExpendituresAmt |
| End Year Balance | $7,089,698 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $7,675,259 | BeginningYearBalanceAmt |
| Contributions | $23,200 | ContributionsAmt |
| Investment Earnings Or Losses | -$221,586 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $192,096 | OtherExpendituresAmt |
| End Year Balance | $7,284,777 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $6,731,177 | BeginningYearBalanceAmt |
| Contributions | $2,650 | ContributionsAmt |
| Investment Earnings Or Losses | $2,218,348 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $1,276,916 | OtherExpendituresAmt |
| End Year Balance | $7,675,259 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $6,808,429 | BeginningYearBalanceAmt |
| Contributions | $1,300 | ContributionsAmt |
| Investment Earnings Or Losses | $106,680 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $185,232 | OtherExpendituresAmt |
| End Year Balance | $6,731,177 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $6,838,821 | BeginningYearBalanceAmt |
| Contributions | $1,480 | ContributionsAmt |
| Investment Earnings Or Losses | $93,478 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $125,350 | OtherExpendituresAmt |
| End Year Balance | $6,808,429 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated Balance EOY | 0.07099 | BoardDesignatedBalanceEOYPct |
| Prmnnt Endowment Balance EOY | 0.72236 | PrmnntEndowmentBalanceEOYPct |
| Term Endowment Balance EOY | 0.20665 | TermEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | 0 | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | 0 | EndowmentsHeldRelatedOrgInd |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $80,945 | OtherCostOrOtherBasisAmt |
| Depreciation | $80,945 | DepreciationAmt |
| Book Value | $0 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $213,363 | OtherCostOrOtherBasisAmt |
| Depreciation | $141,887 | DepreciationAmt |
| Book Value | $71,476 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $71,476 | TotalBookValueLandBuildingsAmt |
| Total Rev Etc Audited Fincl Stmt | $3,238,824 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | -$544,330 | NetUnrealizedGainsInvstAmt |
| Donated Services And Use Fclts | $553,725 | DonatedServicesAndUseFcltsAmt |
| Revenue Not Reported | $9,395 | RevenueNotReportedAmt |
| Revenue Subtotal | $3,229,429 | RevenueSubtotalAmt |
| Investment Expenses Not Incld | $49,316 | InvestmentExpensesNotIncldAmt |
| Revenue Not Reported Fincl Stmt | $49,316 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $3,278,745 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $3,498,076 | TotExpnsEtcAuditedFinclStmtAmt |
| Donated Services Use Fclts | $553,725 | DonatedServicesUseFcltsAmt |
| Expenses Not Reported | $553,725 | ExpensesNotReportedAmt |
| Expenses Subtotal | $2,944,351 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $49,316 | InvestmentExpensesNotIncld2Amt |
| Expenses Not Rpt Fincl Stmt | $49,316 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $2,993,667 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART V, LINE 4: | FormAndLineReferenceDesc |
| Explanation | THE FOUNDATION'S ENDOWMENT PRIMARILY CONSISTS OF CONTRIBUTIONS TO THE JOSEPH A. ODDIS ENDOWMENT CAMPAIGN, THE PURPOSE OF WHICH IS TO RAISE FUNDS FOR PROGRAMS THAT IMPROVE PHARMACY PRACTICE AND THE SAFE AND EFFECTIVE USE OF MEDICATIONS. | ExplanationTxt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (14 entries)
| Address Line1USAddress/AddressLine1Txt | Address Line2USAddress/AddressLine2Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Non Cash AssistanceNonCashAssistanceAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|---|---|
| AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION | |||||||||
| 11325 RANDOM HILLS ROAD SUITE | 360-A105 | FAIRFAX | VA | 22030 | 530214882 | 501(C)3 | $10,000 | $0 | AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION FELLOWSHIP |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | |||||||||
| 4500 EAST-WEST HIGHWAY SUITE 900 | BETHESDA | MD | 20814 | 520807628 | 501(C)6 | $194,741 | $0 | STUDENT LEADERSHIP AWARDS, PHARMACY STUDENT CLINICAL SKILLS COMPETITION, PHARMACY FORECAST REPORT, BIOSIMILARS PROJECT, SPECIALTY PHARMACY SURVEY, DIV PREVENTION ASSESSMENT TOOL GRANTS | |
| DANBURY HOSPITAL & NEW MILFORD HOSPITAL FOUNDATION | |||||||||
| 24 HOSPITAL AVENUE | DANBURY | CT | 06810 | 237425557 | 501(C)3 | $10,000 | $0 | PHARMACY LEADERSHIP SCHOLARS GRANT | |
| LIMA MEMORIAL HOSPITAL | |||||||||
| 1001 BELLEFONTAINE AVENUE | LIMA | OH | 45804 | 341883284 | 501(C)3 | $9,000 | $0 | PHARMACY RESIDENT PRACTIVE-BASED RESEARCH GRANT | |
| MAYO CLINIC HEALTH SYSTEM-SOUTHEAST MINNESOTA REGION | |||||||||
| 1000 FIRST DRIVE NW | AUSTIN | MN | 55912 | 411404075 | 501(C)3 | $30,000 | $0 | OPTIMIZING TECHNOLOGY SOLUTIONS GRANT | |
| RHODE ISLAND HOSPITAL | |||||||||
| 167 POINT STREET BOX 42 CORO EAST - | SUITE 1A | PROVIDENCE | RI | 02903 | 050258954 | 501(C)3 | $26,712 | $0 | PHARMACY RESIDENCY EXPANSION AND PHARMACY RESIDENT PRATICE-BASED RESEARCH GRANT |
| RIVERSIDE HEALTHCARE ASSOCIATION INC | |||||||||
| 608 DENBIGH BLVD STE 800 | NEWPORT NEWS | VA | 23608 | 521241835 | 501(C)3 | $9,806 | $0 | PHARMACY LEADERSHIP SCHOLARS GRANT | |
| SENTARA HOSPITALS | |||||||||
| 6015 POPLAR HALL DR | NORFOLK | VA | 23502 | 541547408 | 501(C)3 | $9,999 | $0 | PHARMACY LEADERSHIP SCHOLARS GRANT | |
| THE MCCLEAN HOSPITAL CORPORATION | |||||||||
| 115 MILL STREET | BELMONT | MA | 02478 | 042697981 | 501(C)3 | $25,000 | $0 | PHARMACY RESIDENCY EXPANSION GRANT | |
| THE METHODIST HOSPITAL | |||||||||
| 6565 FANNIN STREET | HOUSTON | TX | 77030 | 741180155 | 501(C)3 | $29,003 | $0 | RADIO FREQUENCY IDENTIFICATION INITIATIVE | |
| THE METHODIST HOSPITAL FOUNDATION | |||||||||
| 6565 FANNIN STREET SS2 | HOUSTON | TX | 77030 | 760094743 | 501(C)3 | $25,000 | $0 | PHARMACY RESIDENCY EXPANSION GRANT | |
| THE RESEARCH FOUNDATION FOR SUNY | |||||||||
| 35 STATE STREET | ALBANY | NY | 12207 | 141368361 | 501(C)3 | $9,256 | $0 | PHARMACY PRACTICE ADVANCEMENT DEMOSTRATION GRANT | |
| UNIVERSITY OF CINCINNATI | |||||||||
| 51 GOODMAN DRIVE | CINCINNATI | OH | 45221 | 316000989 | STATE UNIVERSITY | $30,000 | $0 | OPTIMIZING TECHNOLOGY SOLUTIONS GRANT | |
| UNIVERSITY OF PITTSBURGH | |||||||||
| PO BOX 640458 | PITTSBURGH | PA | 15264 | 250965591 | 501(C)3 | $30,000 | $0 | COLLABORATIVE CARE GRANT FOR NURSES AND PHARMACISTS | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 13 | Total501c3OrgCnt |
| Total Other Org | 1 | TotalOtherOrgCnt |
Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Type | LITERATURE AWARDS | GrantTypeTxt |
| Recipient | 11 | RecipientCnt |
| Cash Grant | $15,100 | CashGrantAmt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | THE ASHP FOUNDATION HAS A DETAILED REPORTING REQUIREMENT FOR ALL GRANTS AWARDED, WHICH INCLUDES REPORTING PROGRESS AT 6-MONTH INTERVALS. THE ASHP FOUNDATION HAS A GOOD TRACK RECORD OF ENSURING STUDY COMPLETION AND PUBLICATION OF STUDY RESULTS. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Written Employment Contract | Yes (X) | WrittenEmploymentContractInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | Yes (1) | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | Yes (1) | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (1) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (5 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PAUL W ABRAMOWITZ | ||||||||||||||
| PRESIDENT | $0 | $894,671 | $0 | $133,875 | $0 | $27,657 | $0 | $29,600 | $0 | $32,792 | $0 | $1,118,595 | $0 | $0 |
| STEVEN A RUBLOFF | ||||||||||||||
| SECRETARY AND CEO | $332,055 | $0 | $23,500 | $0 | $20,093 | $0 | $29,600 | $0 | $41,943 | $0 | $447,191 | $0 | $0 | $0 |
| BARBARA NUSSBAUM | ||||||||||||||
| VP, RESEARCH AND EDUCATION | $184,553 | $0 | $8,419 | $0 | $1,834 | $0 | $19,897 | $0 | $42,622 | $0 | $257,325 | $0 | $0 | $0 |
| MARTHA CREWS | ||||||||||||||
| VP, DEVELOPMENT | $132,809 | $0 | $6,090 | $0 | $672 | $0 | $14,294 | $0 | $33,739 | $0 | $187,604 | $0 | $0 | $0 |
| STEPHANIE BROWN | ||||||||||||||
| DIRECTOR, OPERATIONS | $123,810 | $0 | $5,261 | $0 | $220 | $0 | $12,436 | $0 | $14,719 | $0 | $156,446 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 6 | PAUL ABRAMOWITZ, PRESIDENT/ASHP CEO, AND STEVEN RUBLOFF, SECRETARY/ASHP REF CEO, RECEIVE A BONUS BASED ON THE ACHIEVEMENT OF SPECIFIC FINANCIAL AND NON-FINANCIAL OUTCOMES FOR THEIR RESPECTIVE ORGANIZATIONS. |
| PART I, LINE 7 | ALL ASHP-REF EMPLOYEES ARE ELIGIBLE FOR AN ANNUAL PERFORMANCE INCENTIVE PROGRAM IN ACCORDANCE WITH POLICY, AT THE DISCRETION OF THE BOARD OF DIRECTORS, BASED ON MUTUALLY AGREED UPON PREDETERMINED OBJECTIVES. |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (8 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART VI, SECTION A, LINE 7A | THREE MANDATORY MEMBERS OF THE FOUNDATION'S BOARD OF DIRECTORS ARE: THE IMMEDIATE PAST PRESIDENT, CEO, AND TREASURER OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS, A RELATED 501(C)(6) MEMBERSHIP ORGANIZATION. THE AFOREMENTIONED TREASURER AND CEO SHALL SERVE, RESPECTIVELY, AS THE TREASURER AND PRESIDENT OF THE FOUNDATION, AND THE IMMEDIATE PAST PRESIDENT SHALL SERVE AS A DIRECTOR OF THE FOUNDATION. THE BOARD OF DIRECTORS OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS MAY ALSO APPOINT ONE OR MORE MEMBERS OF THE PUBLIC TO SERVE AS MEMBERS OF THE FOUNDATION'S BOARD. |
| FORM 990, PART VI, SECTION A, LINE 8B | THERE ARE NO COMMITTEES THAT HAVE THE AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY. |
| FORM 990, PART VI, SECTION B, LINE 11B | THE FORM 990 IS REVIEWED BY OFFICERS OF ASHP AND ASHP FOUNDATION AND BY THE BOARD BEFORE IT IS FILED. EACH MEMBER HAS THE OPPORTUNITY TO REVIEW THE FORM 990. |
| FORM 990, PART VI, SECTION B, LINE 12C | THE CONFLICT OF INTEREST POLICY WILL BE REVIEWED ANNUALLY AT THE SPRING OR FALL MEETING. |
| FORM 990, PART VI, SECTION B, LINE 15A | CHIEF EXECUTIVE OFFICER: PURSUANT TO THE BYLAWS, THE BOARD OF DIRECTORS HAS THE RESPONSIBILITY FOR THE SELECTION AND HIRING OF THE CEO OF THE ORGANIZATION. TEN MEMBERS OF THE BOARD ARE CONSIDERED INDEPENDENT PERSONS AND RECEIVE NO COMPENSATION FROM THE ORGANIZATION. THE BOARD REVIEWS SALARY SURVEY DATA REPORTS FOR OTHER COMPARABLE EXEMPT ORGANIZATIONS AS WELL AS DATA FOR POSITIONS WHICH HAVE SIMILAR RESPONSIBILITIES. OTHER EMPLOYEES WHO ARE EMPLOYED BY THE ORGANIZATION ARE "EMPLOYEES AT WILL". SALARIES FOR THESE INDIVIDUALS ARE DETERMINED USING RELEVANT COMPARABLE SALARY DATA. PRIOR TO FILLING A VACANT POSITION, A HIRING SUPERVISOR, IN CONJUNCTION WITH ASHP'S HUMAN RESOURCES DIVISION, RESEARCHES RELEVANT SALARY RANGES FOR THE POSITION. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE FOUNDATION'S FINANCIAL STATEMENTS, GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. |
| FORM 990, PART IX, LINE 11G | CONTRACT SERVICES: PROGRAM SERVICE EXPENSES 422,175. MANAGEMENT AND GENERAL EXPENSES 364. FUNDRAISING EXPENSES 12,505. TOTAL EXPENSES 435,044. |
| FORM 990, PART XII, LINE 2C: | THE OVERSIGHT PROCESS HAS NOT CHANGED FROM PRIOR YEARS. |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp
Disregarded Entity Name DisregardedEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS (ASHP) | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 4500 EAST-WEST HIGHWAY SUITE 900 | AddressLine1Txt |
| City | BETHESDA | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 520807628 | EIN |
| Primary Activities | TO ADVANCE PUBLIC HEALTH BY SUPPORTING THE PHARMACY PROFESSION | PrimaryActivitiesTxt |
| Legal Domicile State | MD | LegalDomicileStateCd |
| Exempt Code Section | 501(C)(6) | ExemptCodeSectionTxt |
| Direct Controlling NA | N/A | DirectControllingNACd |
| Controlled Organization | 0 | ControlledOrganizationInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | 0 | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | Yes (1) | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | Yes (1) | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | 0 | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | 0 | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | 0 | DivRelatedOrganizationInd |
| Asset Sale To Other Org | 0 | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | 0 | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | 0 | AssetExchangeInd |
| Rental Of Facilities To Oth Org | 0 | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | 0 | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | 0 | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | 0 | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | Yes (1) | SharingOfFacilitiesInd |
| Paid Employees Sharing | Yes (1) | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | Yes (1) | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | 0 | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | 0 | TransferToOtherOrgInd |
| Transfer From Other Org | Yes (1) | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp (6 entries)
| Transaction TypeTransactionTypeTxt | InvolvedInvolvedAmt | Method Of Amount DeterminationMethodOfAmountDeterminationTxt |
|---|---|---|
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | ||
| P | $1,894,251 | RECORDED EXPENSES |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | ||
| S | $1,371,445 | CASH |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | ||
| N | $522,806 | RECORDED EXPENSES |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | ||
| C | $358,050 | CASH |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | ||
| O | $455,610 | FAIR VALUE |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | ||
| B | $194,741 | CASH |